Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2329

Similar articles for PubMed (Select 19724015)

1.

The role of voriconazole in the treatment of central nervous system blastomycosis.

Ta M, Flowers SA, Rogers PD.

Ann Pharmacother. 2009 Oct;43(10):1696-700. doi: 10.1345/aph.1M010. Epub 2009 Sep 1. Review.

PMID:
19724015
3.

Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era.

Bariola JR, Perry P, Pappas PG, Proia L, Shealey W, Wright PW, Sizemore JM, Robinson M, Bradsher RW Jr.

Clin Infect Dis. 2010 Mar 15;50(6):797-804. doi: 10.1086/650579.

4.

Outcomes of persons with blastomycosis involving the central nervous system.

Bush JW, Wuerz T, Embil JM, Del Bigio MR, McDonald PJ, Krawitz S.

Diagn Microbiol Infect Dis. 2013 Jun;76(2):175-81. doi: 10.1016/j.diagmicrobio.2013.03.002. Epub 2013 Apr 5.

PMID:
23566338
5.

Recurrent blastomycosis of the central nervous system: case report and review.

Chowfin A, Tight R, Mitchell S.

Clin Infect Dis. 2000 Jun;30(6):969-71. Review.

6.

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdière M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

N Engl J Med. 2002 Jan 24;346(4):225-34. Erratum in: N Engl J Med. 2007 Feb 15;356(7):760.

7.

Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America.

Chapman SW, Bradsher RW Jr, Campbell GD Jr, Pappas PG, Kauffman CA.

Clin Infect Dis. 2000 Apr;30(4):679-83. Epub 2000 Apr 20.

8.

CNS-aspergillosis: are there new treatment options?

Schwartz S, Thiel E.

Mycoses. 2003;46 Suppl 2:8-14. Review.

PMID:
15055138
9.

Voriconazole: a new triazole antifungal.

Sabo JA, Abdel-Rahman SM.

Ann Pharmacother. 2000 Sep;34(9):1032-43.

PMID:
10981251
10.

Unilateral Blastomyces dermatitidis optic neuropathy case report and systematic literature review.

Pariseau B, Lucarelli MJ, Appen RE.

Ophthalmology. 2007 Nov;114(11):2090-4. Epub 2007 Aug 7.

PMID:
17686521
11.

Voriconazole: a new triazole antifungal agent.

Pearson MM, Rogers PD, Cleary JD, Chapman SW.

Ann Pharmacother. 2003 Mar;37(3):420-32. Review.

PMID:
12639175
12.

Voriconazole.

Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB.

Clin Ther. 2003 May;25(5):1321-81. Review.

PMID:
12867215
13.

Successful treatment of cerebral blastomycosis with voriconazole.

Bakleh M, Aksamit AJ, Tleyjeh IM, Marshall WF.

Clin Infect Dis. 2005 May 1;40(9):e69-71. Epub 2005 Mar 22.

14.

Improved outcome in central nervous system aspergillosis, using voriconazole treatment.

Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA, Schuler U, Lutsar I, Troke P, Thiel E.

Blood. 2005 Oct 15;106(8):2641-5. Epub 2005 Jul 5.

15.

The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Schwartz S, Reisman A, Troke PF.

Infection. 2011 Jun;39(3):201-10. doi: 10.1007/s15010-011-0108-6. Epub 2011 Apr 22.

PMID:
21512792
16.

Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen.

Borgia SM, Fuller JD, Sarabia A, El-Helou P.

Med Mycol. 2006 Nov;44(7):659-64.

PMID:
17071562
17.

Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.

Cesaro S, Toffolutti T, Messina C, Calore E, Alaggio R, Cusinato R, Pillon M, Zanesco L.

Eur J Haematol. 2004 Jul;73(1):50-5.

PMID:
15182338
18.

Voriconazole : a review of its use in the management of invasive fungal infections.

Scott LJ, Simpson D.

Drugs. 2007;67(2):269-98. Review.

PMID:
17284090
19.

Cerebral blastomycosis: a case report.

Chander B, Deb P, Sarkar C, Garg A, Mehta VS, Sharma MC.

Indian J Pathol Microbiol. 2007 Oct;50(4):821-4.

PMID:
18306569
20.

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group.

N Engl J Med. 2002 Aug 8;347(6):408-15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk